Atlas Lithium Corp (ATLX) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US1058613068
Atlas Lithium Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 92,491.00 USD |
| Gross profit | -59,431.00 USD |
| Operating income | -31.65 m USD |
| EBIT | -31.25 m USD |
| Net income | -28.11 m USD |
| Diluted EPS – continuing operations | -1.54 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Atlas Lithium Corp
Atlas Lithium Corporation operates as a mineral exploration and development company in Brazil. It operates the Minas Gerais Lithium project that consists of 85 mineral rights covering an area of 468 square kilometers located in northeastern Minas Gerais, Brazil; and Northeastern Brazil Lithium project covering an area of 71 square kilometers located in the States of Paraíba, Rio Grande do Norte, and Tocantins. The company is also involved in the exploration and development of mineral rights relating to minerals, such as rare earths, copper, titanium, graphite, nickel, iron, gold, and quartzite. The company was formerly known as Brazil Minerals, Inc. and changed its name to Atlas Lithium Corporation in October 2022. Atlas Lithium Corporation was founded in 2011 and is based in Belo Horizonte, Brazil.
More stocks
- NUUO Inc. (6419.TWO)
- Aeon Motor Co Ltd (1599.TWO)
- REGO PAYMENT ARCHITECTURES, INC. (RPMT)
- Werewolf Therapeutics, Inc. (HOWL)
- Rein Therapeutics, Inc. (RNTX)
- LumenRadio AB (LUMEN.ST)
- De Poan Pneumatic (1570.TWO)
- Charlotte's Web Holdings, Inc. (CWBHF)
- EgnsINVEST Ejendomme Tyskland A/S (EGNETY.CO)
- Advagene Biopharma Co. Ltd. (6709.TWO)
- Empresas la Polar SA (ABC.SN)
- DLH Holdings Corp. (DLHC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.